Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Advancing Small Molecule Program From Hit To Candidate (Webinar by Jubilant Biosys)Case Study: Small molecule inhibitors of NMMT for treatment of metabolic disorders
By: Jubilant Biosys Our 4D focused project approach, attributed premier importance to scientific value addition, driving scientific insights about the metabolic therapeutic domain – pharmacological benefits in vivo. In addition, we offer a platform for all the attendants to share their best practices, experiences, and bring in their queries. Webinar Date: Tuesday 8 December 2020, 11:00am EST / 8:00am PST Webinar Takeaways: · Overcoming Hit to Lead challenges · Deciding on the best approach · Fast-tracking Milestone achievement Speaker: Dr. Takeshi Yura Vice President – Medicinal Chemistry Dr. Yura has more than 28 years' experience in Medicinal and Organic Chemistry, beginning his career with Tanabe Seiyaku Tokyo Research Center where he worked as Research Chemist. Post this he was associated with Ciba Geigy Japan (Takarazuka Research Center), Bayer Yakuhin (Research Center Kyoto), Pfizer Japan (Pfizer Global Research and Development Nagoya Laboratories) Before joining Jubilant Biosys, Dr. Yura worked with Albany Molecular Research Singapore Research Centre, Pte. Ltd, as Vice President, Discovery and Development Services for Asia and General Manager for Singapore Research Centre. At AMRI he was responsible for, AMRI Singapore Research Centre's chemistry and biology operations and AMRI Hyderabad Research Centre. Dr. Yura was awarded a Ph.D. degree in Chemistry from the University of Tokyo, Japan. He has completed his Executive MBA program at Temple University, Tokyo, Japan. About Jubilant Biosys Limited: Jubilant Biosys (https://www.jubilantbiosys.com/ For more info, please visit: https://www.jubilantbiosys.com/ SOURCE: Jubilant Biosys Limited Contact Person: Drishti Asthana Ph.: +91-9899033635 E-mail: drishti.asthana@ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|